enGene Holdings is trading at $1.60, up 10.21% on November 3, 2026, with broader biotech strength providing context for the move.
- The biotech ETF XBI was up 2.13%.
- Available company-news search results did not identify a new November 3 company-specific catalyst; the Nasdaq news page showed prior-session price information instead.
- Trading volume and other activity details are unavailable, so trading activity cannot be assessed.